BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/8/2026 9:37:26 AM | Browse: 6 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 113325
Country China
Category Oncology
Manuscript Type Basic Study
Article Title Icariin inhibits tumor-associated neutrophil recruitment via the CXCL8-CXCR2 axis and restrains pro-metastatic programs in colorectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Yan-Hua Zhao, Juan Chen, Tao Gong, Hai-Yan Ge and Min Li
Funding Agency and Grant Number
Corresponding Author Min Li, PhD, Department of Oncology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, No. 157 Daming Road, Nanjing 210022, Jiangsu Province, China. limin_2024@163.com
Key Words Icariin; Neutrophils; Recruitment; C-X-C motif chemokine ligand 8-C-X-C motif chemokine receptor 2 axis; Colorectal cancer; Pro-metastatic program; Progression
Core Tip This study elucidates a novel mechanism by which the natural compound icariin (ICA) combats colorectal cancer. We demonstrate that ICA upregulates the tumor suppressor SMAD4, thereby inhibiting the production of C-X-C motif chemokine ligand 8 (CXCL8) and other C-X-C motif chemokine receptor 2 (CXCR2)-associated chemokines. This action predominantly limits the recruitment of tumor-associated neutrophils (TANs) via the CXCL8-CXCR2 axis. Notably, ICA not only reduces neutrophil infiltration but also reprograms TANs toward an antitumor N1 phenotype. By disrupting this SMAD4-CXCL8-CXCR2-TAN axis, ICA effectively restrains epithelial-mesenchymal transition and other pro-metastatic processes, positioning it as a promising therapeutic candidate with a distinct immunomodulatory strategy against colorectal cancer progression.
Citation Zhao YH, Chen J, Gong T, Ge HY, Li M. Icariin inhibits tumor-associated neutrophil recruitment via the CXCL8-CXCR2 axis and restrains pro-metastatic programs in colorectal cancer. World J Gastroenterol 2026; In press
Received
2025-09-23 09:00
Peer-Review Started
2025-09-23 09:00
First Decision by Editorial Office Director
2025-10-17 06:19
Return for Revision
2025-10-17 06:19
Revised
2025-11-16 07:43
Publication Fee Transferred
2025-11-28 05:50
Second Decision by Editor
2026-01-08 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-08 09:37
Articles in Press
2026-01-08 09:37
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com